Lilly lecture 1990. Molecular defects in diabetes mellitus - PubMed (original) (raw)
Review
Lilly lecture 1990. Molecular defects in diabetes mellitus
G I Bell. Diabetes. 1991 Apr.
Abstract
The application of molecular biology to problems in diabetes mellitus has begun to reveal the underlying molecular defects contributing to the development of hyperglycemia. Islet amyloid represents the most common pathological lesion occurring in the islets of NIDDM subjects. The use of both biochemistry and molecular biology has lead to the identification of the major protein component of human islet amyloid and elucidation of the structure of its precursor. This protein, termed islet amyloid polypeptide, is related to two neuropeptides, calcitonin gene-related peptides 1 and 2, and represents a new beta-cell secretory product whose normal physiological function remains to be determined. The use of molecular biology has also led to a better understanding of the molecular defects contributing to insulin resistance. Characterization of the insulin-receptor gene in patients with extreme forms of insulin resistance has resulted in the identification of mutations that impair its function and lead to tissue resistance to the action of insulin. Molecular biological approaches have also led to a better understanding of the regulation of glucose transport. They have revealed that there is a family of structurally related proteins encoded by distinct genes and expressed in a tissue-specific manner that are responsible for the transport of glucose across the plasma membrane. Moreover, they have shown that specific depletion of the glucose-transporter isoform that mediates insulin-stimulated glucose transport is responsible for decreased transport activity in adipose tissue in insulin-resistant states.
Similar articles
- Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
O'Brien TD, Butler PC, Westermark P, Johnson KH. O'Brien TD, et al. Vet Pathol. 1993 Jul;30(4):317-32. doi: 10.1177/030098589303000401. Vet Pathol. 1993. PMID: 8212454 Review. - Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus.
Cooper GJ, Day AJ, Willis AC, Roberts AN, Reid KB, Leighton B. Cooper GJ, et al. Biochim Biophys Acta. 1989 Dec 14;1014(3):247-58. doi: 10.1016/0167-4889(89)90220-6. Biochim Biophys Acta. 1989. PMID: 2690958 Review. - Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?
Clark A, Nilsson MR. Clark A, et al. Diabetologia. 2004 Feb;47(2):157-69. doi: 10.1007/s00125-003-1304-4. Epub 2004 Jan 13. Diabetologia. 2004. PMID: 14722650 Review. - Molecular biology of mammalian glucose transporters.
Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S. Bell GI, et al. Diabetes Care. 1990 Mar;13(3):198-208. doi: 10.2337/diacare.13.3.198. Diabetes Care. 1990. PMID: 2407475 Review. - Cellular and molecular biology of the beta cell.
Steiner DF, James DE. Steiner DF, et al. Diabetologia. 1992 Dec;35 Suppl 2:S41-8. doi: 10.1007/BF00586278. Diabetologia. 1992. PMID: 1478377 Review.
Cited by
- Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Hotamisligil GS, et al. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854-8. doi: 10.1073/pnas.91.11.4854. Proc Natl Acad Sci U S A. 1994. PMID: 8197147 Free PMC article. - DNAJB3 attenuates metabolic stress and promotes glucose uptake by eliciting Glut4 translocation.
Arredouani A, Diane A, Khattab N, Bensmail I, Aoude I, Chikri M, Mohammad R, Abou-Samra AB, Dehbi M. Arredouani A, et al. Sci Rep. 2019 Mar 18;9(1):4772. doi: 10.1038/s41598-019-41244-8. Sci Rep. 2019. PMID: 30886231 Free PMC article. - Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality.
Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, Bucchini D. Joshi RL, et al. EMBO J. 1996 Apr 1;15(7):1542-7. EMBO J. 1996. PMID: 8612577 Free PMC article. - Multipoint linkage analysis of the short arm of chromosome 11 in non-insulin dependent diabetes including maturity onset diabetes of youth.
O'Rahilly S, Patel P, Lehmann OJ, Tybjaerg-Hansen A, Nerup J, Turner RC, Wainscoat JS. O'Rahilly S, et al. Hum Genet. 1992 May;89(2):207-12. doi: 10.1007/BF00217125. Hum Genet. 1992. PMID: 1587533 - Multiple restriction fragment length polymorphisms at the GLUT2 locus: GLUT2 haplotypes for genetic analysis of type 2 (non-insulin-dependent) diabetes mellitus.
Patel P, Bell GI, Cook JT, Turner RC, Wainscoat JS. Patel P, et al. Diabetologia. 1991 Nov;34(11):817-21. doi: 10.1007/BF00408357. Diabetologia. 1991. PMID: 1685129
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical